查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2100197

眼科醫療設備市場－全球市場預測（2026-2032年）

Ophthalmic Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，眼科醫療設備市場將成長至 417.6 億美元，複合年成長率為 9.53%。

主要市場統計數據
基準年 2025 220.7億美元
預計年份：2026年 239.2億美元
預測年份 2032 417.6億美元
複合年成長率 (%) 9.53%

眼科醫療設備：執行摘要及市場概覽

眼科醫療設備是現代眼科護理的核心，支持白內障、青光眼、糖尿病視網膜病變、老齡化黃斑部病變、屈光不正和乾眼症等眼科疾病的診斷、後續觀察、手術、視力矯正和長期管理。市場需求受到許多公共衛生趨勢的影響，包括人口老化、糖尿病盛行率上升、螢幕使用時間延長以及人們對可預防性視力障礙的認知不斷提高。根據世界衛生組織（WHO）統計，全球至少有22億人患有近視或遠視，其中至少10億人本可預防或無需治療，凸顯了便捷的眼科醫療技術在臨床和經濟方面的重要性。

眼科醫療設備業的變革性變化

眼科醫療設備領域正經歷結構性變革，從以醫療機構為基礎的間歇性診療模式轉向以數據驅動、以患者為中心的持續性眼部健康管理。診斷流程也從人工判斷轉向多模態成像、自動化測量和互通平台，以幫助臨床醫生更早發現疾病進展。光學同調斷層掃描（OCT）、廣角視網膜成像、角膜地圖儀和視野檢查等技術正日益融入白內障手術計劃、青光眼後續觀察、視網膜疾病評估和屈光矯正手術評估等臨床流程。

人工智慧對眼科醫療設備的累積影響

人工智慧 (AI) 透過增強影像分析、提高篩檢效率、最佳化臨床分流和疾病監測，對整體眼科醫療設備產生了累積的影響。人工智慧演算法已在糖尿病視網膜病變篩檢的視網膜影像分析中展現出臨床效用，而獲得監管機構批准的自主或輔助系統正在幫助證明機器學習在眼科醫療服務中的作用。人工智慧也被應用於光學同調斷層掃描(OCT) 影像分析、青光眼風險評估、老齡化黃斑部病變監測、白內障手術計劃、圓錐角膜檢測和工作流程優先排序。

亞太地區、北美地區、歐洲地區、拉丁美洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區人口基數龐大，白內障和屈光不正發病率高，糖尿病盛行率不斷上升，且眼科醫療基礎設施投資持續成長，因此成為眼科醫療設備的主要需求中心。中國、印度、日本、韓國和澳洲等國家正透過先進的影像技術、手術平台、人工水晶體和社區篩檢模式來加強眼科醫療服務。此外，該地區都市區三級醫療機構與農村地區在醫療服務取得方面存在差距，因此攜帶式眼底攝影機、遠距眼科診療和人工智慧輔助篩檢尤為重要。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東南亞國協，醫療衛生系統正優先進行可預防性失明預防、白內障治療和糖尿病視網膜病變篩檢，以應對人口成長、都市化以及非傳染性疾病負擔日益加重等問題。該地區既有先進的私立醫院，也有醫療服務不足的農村人口，這使得高階眼科手術系統和價格適中、便於攜帶式的診斷設備都面臨著巨大的需求。

針對主要眼科醫療設備市場的關鍵國別洞察

美國擁有高度發展的眼科醫療設備體系，這得益於光學同調斷層掃描（OCT）、眼底成像、高階人工水晶體、青光眼診斷和門診手術中心的廣泛應用。加拿大強調各省醫療保健系統之間的公平醫療服務、糖尿病眼科疾病篩檢以及聯網診斷系統的實施。墨西哥正透過公立和私立眼科中心的結合，擴大白內障、屈光和視網膜疾病的治療。同時，巴西擁有拉丁美洲最先進的眼科醫療體系之一，對白內障手術、視網膜影像和糖尿病眼科疾病治療的需求強勁。

為眼科醫療設備業的領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的創新，以提高早期檢測、治療準確性、工作流程效率和醫療服務可近性。產品策略應著重於可互通的影像系統、人工智慧診斷、攜帶式篩檢設備、先進的人工水晶體、微創手術平台以及便於患者使用的監測工具。製造商和解決方案供應商應開發符合眼科醫生工作流程、驗光師主導的篩檢模式、門診手術中心的需求以及預防失明公共衛生優先事項的解決方案。

眼科醫療設備分析的調查方法

本執行摘要採用系統性的二手研究途徑，利用檢驗且公開可用的資訊來源編寫而成。研究框架包括全球公共衛生出版物、眼科臨床指南、監管文件、同行評審研究、政府衛生資料、專業學會資料以及醫療設備政策參考資料的審查。分析重點在於技術採納模式、臨床應用案例、監管趨勢、疾病負擔指標、醫療服務模式以及區域醫療基礎設施發展趨勢。

結論：推動眼科護理的準確性、可及性和數位化創新。

隨著醫療保健系統不斷調整以應對視力障礙、白內障、青光眼、糖尿病視網膜病變、老齡化黃斑部病變、屈光不正和乾眼症等疾病日益加重的負擔，眼科醫療設備領域正在迅速發展。臨床精準性、數位化連接、人工智慧和以易用性為中心的設計理念融合的領域，正湧現出最大的商業機會。診斷影像、人工智慧輔助篩檢、先進的手術系統、人工水晶體創新以及攜帶式眼科技術正在重新定義眼科疾病的檢測、治療和後續觀察方式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 眼科醫療設備市場：依產品類型分類

  • 診斷和監測設備
    • 眼底攝影機
    • 眼底鏡
    • 角膜厚度測量儀
  • 外科器械
  • 視力保健產品
  • 眼科耗材

第8章：眼科醫療設備市場：依技術分類

  • 雷射技術
  • 光學成像

第9章：眼科醫療設備市場：依應用領域分類

  • 白內障手術
  • 乾眼症管理
  • 青光眼手術
  • 屈光矯正手術
  • 玻璃體視網膜手術

第10章：眼科醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 眼科診所
  • 眼鏡零售商
  • 研究和學術機構

第11章：眼科醫療設備市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 眼科醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 眼科醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Alcon Inc.
  • Bausch & Lomb Incorporated
  • BVI Medical, Inc.
  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • Dutch Ophthalmic Research Center International BV
  • Ellex Medical Lasers Limited
  • EssilorLuxottica SA
  • Glaukos Corporation
  • Haag-Streit Holding AG
  • Heidelberg Engineering GmbH
  • HOYA Corporation
  • Johnson & Johnson Vision Care, Inc.
  • Keeler Limited
  • Lumenis Be Ltd.
  • Medmont International Pty Ltd
  • NIDEK Co., Ltd.
  • OCULUS Optikgerate GmbH
  • Optopol Technology Sp. z oo
  • Optos plc
  • Optovue, Inc.
  • Quantel Medical SAS
  • Rayner Intraocular Lenses Limited
  • Sonomed Escalon
  • STAAR Surgical Company
  • The Cooper Companies, Inc.
  • Tomey Corporation
  • Topcon Corporation
  • Volk Optical Inc.
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-742BD518297E

The Ophthalmic Devices Market is projected to grow by USD 41.76 billion at a CAGR of 9.53% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 22.07 billion
Estimated Year [2026] USD 23.92 billion
Forecast Year [2032] USD 41.76 billion
CAGR (%) 9.53%

Ophthalmic Devices: Executive Summary and Market Context

Ophthalmic devices are central to modern eye care, supporting diagnosis, monitoring, surgery, vision correction, and long-term management of ocular disorders such as cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, refractive errors, and dry eye disease. Demand is being shaped by well-documented public health trends, including population aging, rising diabetes prevalence, sustained screen exposure, and growing awareness of preventable vision impairment. The World Health Organization has reported that at least 2.2 billion people globally have near or distance vision impairment, and at least 1 billion cases could have been prevented or remain unaddressed, underscoring the clinical and economic importance of accessible ophthalmic technology.

The ophthalmic devices landscape spans diagnostic imaging systems, optical coherence tomography, fundus cameras, tonometers, slit lamps, intraocular lenses, phacoemulsification platforms, ophthalmic lasers, contact lenses, surgical instruments, and digital eye health solutions. Innovation is increasingly focused on earlier detection, higher procedural precision, improved patient comfort, remote monitoring, and workflow efficiency. Healthcare systems are also prioritizing scalable screening models for diabetic eye disease and glaucoma, while outpatient and ambulatory settings continue to adopt compact, automated, and connected devices to expand access to high-quality eye care.

Transformative Shifts in the Ophthalmic Devices Landscape

The ophthalmic devices sector is undergoing a structural transition from episodic, facility-based care toward continuous, data-enabled, and patient-centered eye health management. Diagnostic workflows are shifting from manual interpretation toward multimodal imaging, automated measurements, and interoperable platforms that help clinicians detect disease progression earlier. Optical coherence tomography, widefield retinal imaging, corneal topography, biometry, and visual field testing are increasingly integrated into clinical pathways for cataract planning, glaucoma monitoring, retinal disease assessment, and refractive surgery evaluation.

Surgical ophthalmology is also advancing through micro-incision techniques, improved intraocular lens designs, femtosecond and excimer laser platforms, enhanced phacoemulsification systems, and image-guided planning tools. These advances support better refractive outcomes, shorter recovery times, and more individualized procedures. At the same time, teleophthalmology and portable diagnostic devices are becoming important in rural, primary care, employer-based, and community screening environments. Regulatory expectations for cybersecurity, software validation, clinical evidence, and post-market surveillance are also reshaping product development strategies, especially as connected and AI-enabled ophthalmic devices become more common.

Cumulative Impact of Artificial Intelligence on Ophthalmic Devices

Artificial intelligence is having a cumulative impact across ophthalmic devices by enhancing image analysis, screening efficiency, clinical triage, and disease monitoring. AI algorithms have demonstrated clinical utility in analyzing retinal images for diabetic retinopathy screening, and regulatory-cleared autonomous or assistive systems have helped validate the role of machine learning in eye care delivery. AI is also being applied to optical coherence tomography interpretation, glaucoma risk assessment, age-related macular degeneration monitoring, cataract surgery planning, keratoconus detection, and workflow prioritization.

The most significant value of AI in ophthalmology is not limited to automation; it lies in enabling earlier intervention and scalable access. In high-volume screening programs, AI-assisted image grading can reduce specialist burden and improve referral consistency. In clinical settings, decision-support tools can synthesize imaging, intraocular pressure, visual field data, and patient history to support longitudinal assessment. However, responsible deployment requires transparent validation across diverse populations, explainability where clinically relevant, bias monitoring, secure data governance, and alignment with medical device software regulations. The convergence of AI, cloud connectivity, and ophthalmic imaging is expected to make preventive eye care more proactive, particularly in diabetic eye disease and glaucoma pathways.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is a major center of ophthalmic device demand due to its large population base, high burden of cataract and refractive errors, rising diabetes prevalence, and expanding investments in eye care infrastructure. Countries such as China, India, Japan, South Korea, and Australia are strengthening ophthalmology services through advanced imaging, surgical platforms, intraocular lenses, and community screening models. The region also faces access disparities between urban tertiary centers and rural communities, making portable fundus cameras, teleophthalmology, and AI-assisted screening particularly relevant.

North America benefits from established reimbursement pathways, a high concentration of specialized ophthalmology practices, broad adoption of optical coherence tomography and retinal imaging, and continued use of advanced cataract and refractive surgery technologies. The United States and Canada are emphasizing early detection of diabetic retinopathy, glaucoma, and macular degeneration, supported by clinical guidelines, digital health infrastructure, and growing use of connected diagnostic tools.

Latin America is characterized by expanding access to cataract surgery, diabetic eye screening, and refractive care, with Brazil and Mexico acting as important adoption hubs for ophthalmic imaging and surgical equipment. Public health systems and private providers are increasingly focused on reducing avoidable blindness, though infrastructure gaps, affordability, and specialist distribution remain important factors influencing ophthalmic device utilization.

Europe has strong clinical adoption of diagnostic imaging, ophthalmic lasers, premium intraocular lenses, and surgical planning systems, supported by mature regulatory oversight and extensive public health eye care pathways. The region's aging population is increasing clinical attention on cataract, glaucoma, and retinal diseases. The Middle East is advancing through investment in specialty hospitals, medical tourism, and high-end surgical and diagnostic ophthalmology, particularly in Gulf economies. Africa faces a substantial burden of preventable vision impairment and uneven access to ophthalmologists, making low-cost diagnostic tools, mobile eye clinics, cataract surgery programs, and teleophthalmology critical for improving outcomes.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN countries are prioritizing preventable blindness initiatives, cataract services, and diabetic retinopathy screening as health systems respond to population growth, urbanization, and increased noncommunicable disease burden. The region's mix of advanced private hospitals and underserved rural populations creates demand for both premium ophthalmic surgical systems and affordable portable diagnostic devices.

The GCC is distinguished by significant investment in specialty care, high healthcare digitization ambitions, and demand for advanced cataract, refractive, retinal, and glaucoma technologies. Diabetes prevalence in several Gulf countries has strengthened the need for systematic retinal screening and integrated ophthalmic imaging.

The European Union provides a sophisticated regulatory and clinical environment for ophthalmic devices, with emphasis on patient safety, clinical evidence, data protection, and cross-border quality standards. EU healthcare systems support broad uptake of optical coherence tomography, ophthalmic lasers, biometry, and intraocular lens technologies, particularly in aging populations.

BRICS countries represent diverse but influential ophthalmic device environments. China and India combine large patient populations with expanding domestic manufacturing and eye care access programs; Brazil and South Africa are focused on public-private efforts to address cataract and diabetic eye disease; and Russia maintains demand for surgical and diagnostic ophthalmology across major urban centers. G7 countries generally lead in adoption of advanced diagnostics, AI-enabled workflows, premium surgical technologies, and evidence-based clinical pathways. NATO members, overlapping substantially with North America and Europe, benefit from established healthcare infrastructure, regulatory harmonization efforts, military and veteran eye care needs, and growing attention to resilience in medical technology supply chains.

Key Country Insights in Major Ophthalmic Device Markets

The United States remains a highly advanced ophthalmic devices environment, supported by widespread use of optical coherence tomography, fundus imaging, premium intraocular lenses, glaucoma diagnostics, and outpatient surgical centers. Canada emphasizes equitable access, diabetic eye screening, and adoption of connected diagnostic systems across provincial health structures. Mexico is expanding cataract, refractive, and retinal care through a combination of public programs and private ophthalmology centers, while Brazil has one of Latin America's most developed ophthalmology ecosystems with strong demand for cataract surgery, retinal imaging, and diabetic eye disease management.

In Europe, the United Kingdom continues to prioritize ophthalmology capacity, community eye care, and digital referral pathways, particularly for cataract, glaucoma, and retinal disease. Germany is a leading adopter of precision diagnostics, ophthalmic lasers, surgical microscopes, and intraocular lens technologies, supported by strong specialist infrastructure. France maintains robust ophthalmic care pathways and growing demand for imaging and surgical devices linked to aging-related eye disease. Italy and Spain have significant cataract and refractive surgery activity, with ongoing adoption of advanced biometry, phacoemulsification, and retinal imaging systems. Russia's demand is concentrated in major clinical centers where cataract, glaucoma, and retinal disease management drive equipment utilization.

In Asia-Pacific, China is expanding ophthalmology capacity through hospital investment, screening programs, and domestic medical device capability, with strong needs in myopia control, cataract surgery, and diabetic retinopathy monitoring. India faces a large burden of cataract, refractive error, and diabetic eye disease, making affordability, high-volume surgery, portable diagnostics, and teleophthalmology especially important. Japan's aging population supports advanced adoption of retinal imaging, glaucoma monitoring, cataract surgery systems, and intraocular lenses. Australia emphasizes evidence-based eye care, rural outreach, diabetic retinopathy screening, and digital health integration. South Korea combines high technology adoption with strong refractive surgery, cataract, retinal, and diagnostic imaging capabilities.

Actionable Recommendations for Ophthalmic Device Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves earlier detection, procedural accuracy, workflow efficiency, and access to care. Product strategies should focus on interoperable imaging systems, AI-assisted diagnostics, portable screening devices, advanced intraocular lenses, minimally invasive surgical platforms, and patient-friendly monitoring tools. Manufacturers and solution providers should align development with ophthalmologist workflows, optometrist-led screening models, ambulatory surgery center needs, and public health priorities for avoidable blindness.

To strengthen competitiveness, leaders should invest in diverse clinical validation, real-world evidence generation, cybersecurity-by-design, regulatory readiness, and post-market performance monitoring. Partnerships with hospitals, eye institutes, diabetes clinics, primary care networks, and telehealth providers can expand screening reach and improve referral pathways. In emerging and underserved regions, tiered product portfolios, training programs, remote support, and cost-effective service models can improve adoption. Organizations should also build resilient supply chains for optical components, sensors, lenses, electronic modules, and sterilized surgical consumables while maintaining quality and compliance across jurisdictions.

Research Methodology for Ophthalmic Devices Analysis

This executive summary is developed through a structured secondary research approach using verified, publicly available, and evidence-based sources. The research framework includes review of global public health publications, ophthalmology clinical guidelines, regulatory documentation, peer-reviewed studies, government health resources, professional society materials, and medical device policy references. The analysis focuses on technology adoption patterns, clinical use cases, regulatory developments, disease burden indicators, care delivery models, and regional healthcare infrastructure trends.

The methodology emphasizes triangulation across authoritative sources to ensure accuracy and relevance while avoiding unsupported estimates, market sizing, market share calculations, or forecasts. Insights are synthesized across product categories, including diagnostic imaging devices, ophthalmic surgical systems, intraocular lenses, lasers, contact lenses, monitoring tools, and AI-enabled software. Regional, group, and country-level perspectives are assessed based on healthcare access, disease burden, demographic trends, reimbursement context, regulatory environment, and digital health maturity.

Conclusion: Advancing Precision, Access, and Digital Innovation in Eye Care

The ophthalmic devices sector is advancing rapidly as healthcare systems respond to the growing burden of vision impairment, cataract, glaucoma, diabetic retinopathy, macular degeneration, refractive errors, and dry eye disease. The strongest opportunities are emerging where clinical precision, digital connectivity, artificial intelligence, and access-focused design converge. Diagnostic imaging, AI-assisted screening, advanced surgical systems, intraocular lens innovation, and portable eye care technologies are redefining how eye diseases are detected, treated, and monitored.

Future success in ophthalmic devices will depend on evidence-backed innovation, regulatory discipline, affordability, interoperability, and the ability to support clinicians across both advanced hospitals and resource-limited care settings. Organizations that align product development with preventive eye health, scalable screening, minimally invasive treatment, and secure digital workflows will be best positioned to support improved vision outcomes worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ophthalmic Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Diagnostic & Monitoring Devices
    • 7.2.1. Fundus Cameras
    • 7.2.2. Ophthalmoscopes
    • 7.2.3. Pachymeters
  • 7.3. Surgical Devices
  • 7.4. Vision Care Products
  • 7.5. Ophthalmic Consumables

8. Ophthalmic Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Laser Technology
  • 8.3. Optical Imaging

9. Ophthalmic Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Cataract Surgery
  • 9.3. Dry Eye Management
  • 9.4. Glaucoma Surgery
  • 9.5. Refractive Surgery
  • 9.6. Vitreoretinal Surgery

10. Ophthalmic Devices Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Hospitals
  • 10.4. Ophthalmic Clinics
  • 10.5. Optical Retail Stores
  • 10.6. Research & Academic Institutes

11. Ophthalmic Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Ophthalmic Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Ophthalmic Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Alcon Inc.
  • 15.2. Bausch & Lomb Incorporated
  • 15.3. BVI Medical, Inc.
  • 15.4. Canon Medical Systems Corporation
  • 15.5. Carl Zeiss Meditec AG
  • 15.6. Dutch Ophthalmic Research Center International B.V.
  • 15.7. Ellex Medical Lasers Limited
  • 15.8. EssilorLuxottica SA
  • 15.9. Glaukos Corporation
  • 15.10. Haag-Streit Holding AG
  • 15.11. Heidelberg Engineering GmbH
  • 15.12. HOYA Corporation
  • 15.13. Johnson & Johnson Vision Care, Inc.
  • 15.14. Keeler Limited
  • 15.15. Lumenis Be Ltd.
  • 15.16. Medmont International Pty Ltd
  • 15.17. NIDEK Co., Ltd.
  • 15.18. OCULUS Optikgerate GmbH
  • 15.19. Optopol Technology Sp. z o.o.
  • 15.20. Optos plc
  • 15.21. Optovue, Inc.
  • 15.22. Quantel Medical SAS
  • 15.23. Rayner Intraocular Lenses Limited
  • 15.24. Sonomed Escalon
  • 15.25. STAAR Surgical Company
  • 15.26. The Cooper Companies, Inc.
  • 15.27. Tomey Corporation
  • 15.28. Topcon Corporation
  • 15.29. Volk Optical Inc.
  • 15.30. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL OPHTHALMIC DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL OPHTHALMIC DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL OPHTHALMIC DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL OPHTHALMIC DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL OPHTHALMIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL OPHTHALMIC DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL OPHTHALMIC DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC & MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC & MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC & MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FUNDUS CAMERAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FUNDUS CAMERAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FUNDUS CAMERAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PACHYMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PACHYMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PACHYMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VISION CARE PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VISION CARE PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VISION CARE PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMIC CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMIC CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMIC CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LASER TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LASER TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LASER TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPTICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATARACT SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CATARACT SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATARACT SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DRY EYE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DRY EYE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DRY EYE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLAUCOMA SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GLAUCOMA SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLAUCOMA SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REFRACTIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REFRACTIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REFRACTIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VITREORETINAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VITREORETINAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VITREORETINAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OPHTHALMIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OPTICAL RETAIL STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OPTICAL RETAIL STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OPTICAL RETAIL STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GCC OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. GCC OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. G7 OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. G7 OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. NATO OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. NATO OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. CANADA OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CANADA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CANADA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. CANADA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. CANADA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. CANADA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 151. MEXICO OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. MEXICO OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MEXICO OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. MEXICO OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. MEXICO OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. MEXICO OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 157. BRAZIL OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. BRAZIL OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. BRAZIL OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. BRAZIL OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. BRAZIL OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRAZIL OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED KINGDOM OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED KINGDOM OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED KINGDOM OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED KINGDOM OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED KINGDOM OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED KINGDOM OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 169. GERMANY OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. GERMANY OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GERMANY OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. GERMANY OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. GERMANY OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GERMANY OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 175. FRANCE OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. FRANCE OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. FRANCE OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. FRANCE OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. FRANCE OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. FRANCE OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 181. RUSSIA OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. RUSSIA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. RUSSIA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. RUSSIA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. RUSSIA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. RUSSIA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 187. ITALY OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. ITALY OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ITALY OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. ITALY OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ITALY OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ITALY OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 193. SPAIN OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. SPAIN OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. SPAIN OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. SPAIN OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. SPAIN OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. SPAIN OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. INDIA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. INDIA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. INDIA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. INDIA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. INDIA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 211. JAPAN OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. JAPAN OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. JAPAN OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. JAPAN OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. JAPAN OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. JAPAN OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 217. AUSTRALIA OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. AUSTRALIA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AUSTRALIA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. AUSTRALIA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. AUSTRALIA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. AUSTRALIA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA OPHTHALMIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. SOUTH KOREA OPHTHALMIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. SOUTH KOREA OPHTHALMIC DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. SOUTH KOREA OPHTHALMIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. SOUTH KOREA OPHTHALMIC DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. SOUTH KOREA OPHTHALMIC DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL OPHTHALMIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 230. GLOBAL OPHTHALMIC DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025